1. Effect of MAOA rs1465108 polymorphism on susceptibility to substance/alcohol use disorder: a novel PCR-RFLP assay for the detection of MAOA rs1465108
   Dilek Kaya-Akyüzlü et al, 2024, Molecular Biology Reports CrossRef
2. Sex-Dependent Alterations in the mRNA Expression of Enzymes Involved in Dopamine Synthesis and Breakdown After Methamphetamine Self-Administration
   Aaron E. Miller et al, 2022, Neurotoxicity Research CrossRef
3. A genome-wide association, polygenic risk score and sex study on opioid use disorder treatment outcomes
   Alannah McEvoy et al, 2023, Scientific Reports CrossRef
4. Risk and Resilience Variants in the Retinoic Acid Metabolic and Developmental Pathways Associated with Risk of FASD Outcomes
   Leo McKay et al, 2024, Biomolecules CrossRef
5. The pleiotropic contribution of genes in dopaminergic and serotonergic pathways to addiction and related behavioral traits
   Ester Antón-Galindo et al, 2023, Frontiers in Psychiatry CrossRef
6. The Role of Environment, Early Use, Genetic Influences, and Neurobiology in Substance Use Disorder
   Linda Stone et al, 2023, Nursing Clinics of North America CrossRef
7. Transcriptomic characterization of 2D and 3D human induced pluripotent stem cell-based in vitro models as New Approach Methodologies for developmental neurotoxicity testing
   Malene Lislien et al, 2025, Toxicology CrossRef
8. Disfunción sexual y uso de drogas en mujeres: una relación etiológica recíproca
   Andrés Felipe Calvo-Abaunza et al, 2021, Revista Colombiana de Obstetricia y Ginecología CrossRef
9. Craving: explanatory models, associated factors, and therapeutic approaches: A systematic review
   Olena Klimenko et al, 2024, Psicoespacios CrossRef
10. Epigenetic regulation of GABA catabolism in iPSC-derived neurons: The molecular links between FGF21 and histone methylation
    Ming-Fen Ho et al, 2023, Molecular Metabolism CrossRef
11. Gene Variant Frequencies of IDO1, IDO2, TDO, and KMO in Substance Use Disorder Cohorts
    Lindsey Contella et al, 2024, Genes CrossRef
12. Medication overuse headache
    Sait Ashina et al, 2023, Nature Reviews Disease Primers CrossRef
13. Genetics of cannabis use in opioid use disorder: A genome-wide association and polygenic risk score study
    Alannah Hillmer et al, 2023, PLOS ONE CrossRef
14. Soul, body and mental health – applying Rabbi Moshe de Maimon’s philosophy to the contemporary phenomenon of drug addiction
    Yula Milshteyn, 2024, History of Psychiatry CrossRef
15. The distinct roles of various neurotransmitters in modulating methamphetamine-induced conditioned place preference in relevant brain regions in mice
    Hongliang Su et al, 2022, NeuroReport CrossRef
16. EYERUBBICS: The Eye Rubbing Cycle Study
    Alexandre Hage et al, 2023, Journal of Clinical Medicine CrossRef
17. Integrating the Roles of Midbrain Dopamine Circuits in Behavior and Neuropsychiatric Disease
    Allen PF Chen et al, 2021, Biomedicines CrossRef
18. Engagement and response to a psychoeducation program for family members of inpatients undergoing treatment for substance use disorder
    Claudia Cristina de Oliveira Camargo et al, 2023, Journal of Marital and Family Therapy CrossRef
19. Identifying predictors of multi-year cannabis vaping in U.S. Young adults using machine learning
    Siyoung Choe et al, 2025, Addictive Behaviors CrossRef
20. Neuroplasticity and Multilevel System of Connections Determine the Integrative Role of Nucleus Accumbens in the Brain Reward System
    Martyna Bayassi-Jakowicka et al, 2021, International Journal of Molecular Sciences CrossRef
21. The SEEKING Drive and Its Fixation: A Neuro-Psycho-Evolutionary Approach to the Pathology of Addiction
    Antonio Alcaro et al, 2021, Frontiers in Human Neuroscience CrossRef
22. FOXN3 and GDNF Polymorphisms as Common Genetic Factors of Substance Use and Addictive Behaviors
    Andrea Vereczkei et al, 2022, Journal of Personalized Medicine CrossRef